A case of gastric cancer with delayed onset of tumor reduction effect by nivolumab therapy

Immune checkpoint inhibitors may have different clinical effects compared with conventional anticancer drugs. An 85-year-old male received chemotherapy for recurrent gastric cancer. As liver metastasis progressed, nivolumab was introduced as a fourth line treatment. Progression of liver metastasis i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical journal of gastroenterology 2019-02, Vol.12 (1), p.15-19
Hauptverfasser:	Satoyoshi, Rika, Muto, Osamu, Masuda, Akio, Kotanagi, Kei, Kichiraku, Takuya, Kudoh, Kazuhiro, Sawada, Toshiya, Miyazawa, Hideaki, Kotanagi, Hitoshi
Format:	Artikel
Sprache:	eng
Schlagworte:	Abdominal Surgery Adenocarcinoma - diagnostic imaging Adenocarcinoma - drug therapy Adenocarcinoma - secondary Aged, 80 and over Antineoplastic Agents, Immunological - therapeutic use Case Report Colorectal Surgery Disease Progression Gastroenterology Hepatology Humans Liver Neoplasms - diagnostic imaging Liver Neoplasms - drug therapy Liver Neoplasms - secondary Male Medicine Medicine & Public Health Neoplasm Recurrence, Local - drug therapy Neoplasm Recurrence, Local - pathology Nivolumab - therapeutic use Stomach Neoplasms - drug therapy Stomach Neoplasms - pathology Surgical Oncology Time Factors Tomography, X-Ray Computed Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!